DE69925829D1 - Kurzes peptid zur behandlung neurodegenerativer erkrankungen - Google Patents

Kurzes peptid zur behandlung neurodegenerativer erkrankungen

Info

Publication number
DE69925829D1
DE69925829D1 DE69925829T DE69925829T DE69925829D1 DE 69925829 D1 DE69925829 D1 DE 69925829D1 DE 69925829 T DE69925829 T DE 69925829T DE 69925829 T DE69925829 T DE 69925829T DE 69925829 D1 DE69925829 D1 DE 69925829D1
Authority
DE
Germany
Prior art keywords
gpl20
treatment
chemokines
peptide
brief
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925829T
Other languages
English (en)
Inventor
Candace Pert
Michael Ruff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Immuni T Inc
Original Assignee
Advanced Immuni T Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Immuni T Inc filed Critical Advanced Immuni T Inc
Application granted granted Critical
Publication of DE69925829D1 publication Critical patent/DE69925829D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE69925829T 1998-04-06 1999-04-06 Kurzes peptid zur behandlung neurodegenerativer erkrankungen Expired - Lifetime DE69925829D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8083698P 1998-04-06 1998-04-06
PCT/US1999/007514 WO1999051254A1 (en) 1998-04-06 1999-04-06 Short peptides for treatment of neurological degenerative diseases

Publications (1)

Publication Number Publication Date
DE69925829D1 true DE69925829D1 (de) 2005-07-21

Family

ID=22159933

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925829T Expired - Lifetime DE69925829D1 (de) 1998-04-06 1999-04-06 Kurzes peptid zur behandlung neurodegenerativer erkrankungen

Country Status (7)

Country Link
EP (1) EP1075270B1 (de)
JP (1) JP2002510641A (de)
AT (1) ATE297942T1 (de)
AU (1) AU744044B2 (de)
CA (1) CA2327811A1 (de)
DE (1) DE69925829D1 (de)
WO (1) WO1999051254A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100719202B1 (ko) 1998-10-23 2007-05-16 키린-암젠 인코포레이티드 ＭＰｌ 수용체에 결합하는 화합물 및 이를 함유하는 제약학적 조성물
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US7041506B2 (en) * 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
US8143380B2 (en) 2004-07-08 2012-03-27 Amgen Inc. Therapeutic peptides
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
JO3324B1 (ar) 2006-04-21 2019-03-13 Amgen Inc مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
AT509611B1 (de) * 2008-06-12 2012-04-15 Affiris Forschungs-Und Entwicklungs Gmbh Vakzin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276016A (en) * 1986-06-03 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Small peptides which inhibit binding to T-4 receptors and act as immunogens
US5567682A (en) * 1988-12-16 1996-10-22 Advanced Peptides And Biotechnology Sciences Method of treating Alzheimer's disease

Also Published As

Publication number Publication date
WO1999051254A1 (en) 1999-10-14
AU744044B2 (en) 2002-02-14
EP1075270B1 (de) 2005-06-15
JP2002510641A (ja) 2002-04-09
EP1075270A1 (de) 2001-02-14
ATE297942T1 (de) 2005-07-15
AU3473599A (en) 1999-10-25
CA2327811A1 (en) 1999-10-14
EP1075270A4 (de) 2004-03-03

Similar Documents

Publication Publication Date Title
CY1121447T1 (el) Συνθεσεις για αυξηση δραστηριοτητας τελομερασης
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
Kozlowski et al. Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules.
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
BR0009964A (pt) Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial
DE69925829D1 (de) Kurzes peptid zur behandlung neurodegenerativer erkrankungen
ATE337339T1 (de) Therapeutische verwendung von smr1 protein und seinen aktiven derivaten
BR9808804A (pt) Processos para tratar um indivìduo para melhorar o funcionamento do trato gastrointestinal superior incluindo o esÈfago e o estÈmago, para tratar um indivìduo para proliferar o tecido do trato gastrointestinal superior, para identificar peptìdeos utilizável para tratar condições inflamatórias, para identificar peptìdeos, utilizável para evitar ou melhorar as condições inflamatórias, utilizável para identificar peptìdeos capazes de proliferar tecido do trato gastrointestinal superior, para tratar profilaticamente um indivìduo, para melhorar o crescimento do tecido do trato gastrointestinal superior em um mamìfero, e para tratar um indivìduo para melhorar o funcionamento do trato gastrointestinal superior, kit, processos para promover o crescimento de tecido do trato gastrointestinal superior ou células, para tratar um paciente para restaurar o trato gastrointestinal superior, para determinar a atividade de um hormÈnio quando usado em combinação com glp-2, para tratar um indivìduo tendo úlceras peptìdicas
US5627035A (en) Peptides that block human immunodeficiency virus and methods of use thereof
CN101679495B (zh) 用于细胞学和免疫学调节的短的生物活性肽
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
CN110114060A (zh) 具有杀菌作用的制剂
WO2000073427A3 (en) Acetylcholinesterase-derived peptides and uses thereof
PT759772E (pt) Tri- tetra- penta e polipeptidos e a sua utilizacao terapeutica como agente antidepressivo
Zammit et al. Macrophage response during axonal regeneration in the axolotl central and peripheral nervous system
ATE373091T1 (de) Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
US6011014A (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
EP0415999B1 (de) Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
ES2134254T3 (es) Expresion del factor osteogenico op-1 de celulas de spodoptera frugiperda infectadas con baculovirus recombinante.
FR2745185B1 (fr) Utilisation de l'il-7 dans le traitement des maladies auto-immunes, en particulier le diabete mellitus insulinodependant
AU1318797A (en) Peptides and uses thereof for therapy of celiac diseases
Schlemm et al. Medicinal yeast extracts
EP1760090A1 (de) Regulatorische/entfaltende Peptide von Ezrin
ATE203680T1 (de) Konjugat zur behandlung von entzündungserkrankungen

Legal Events

Date Code Title Description
8332 No legal effect for de